MedPath

Effectiveness of intra tympanic injection of the mixture of Dexamethason+hyaluronic acid in the treatment of sudden hearing loss.

Not Applicable
Conditions
Condition 1: Hearing loss. Condition 2: Sudden hearing loss.
Sudden idiopathic hearing loss
Registration Number
IRCT201611306699N3
Lead Sponsor
Vice Chancellor for Research, Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

The inclusion criteria consisted of unilateral hearing loss (occurring within 72 hours), the hearing threshold average greater than 50 dB, symptoms appearance within 7 days from our intervention, patient's pure tone audiogram at frequencies 250 500, 1000, 2000, 4000 and 8000 Hz, age range 18-80 years, lack of acoustic tumor, middle ear diseases, autoimmune diseases, vestibular problem (Menier disease&..), cardiovascular disorders and diabetes, no history of ear surgery and the patient’s consent to participate in the study.
Meanwhile patient’s refusal to attend on time for follow up visits, any limitation to inject intra tympanum via external auditory canal such as stenosis, anatomical deformities and external and middle ear infections were considered as exclusion criteria.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hearing threshold in different frequencies. Timepoint: Before & two weeks after intervention. Method of measurement: Pure tone audiometry.
Secondary Outcome Measures
NameTimeMethod
Infection. Timepoint: One week after intervention. Method of measurement: Ear examination.
© Copyright 2025. All Rights Reserved by MedPath